FindTrial
Sign In

Evaluation of hepatic vessels by transesophageal echocardiography during living donor liver transplantation.

Trans-esophageal echocardiographic assessment of hepatic vasculature in patients undergoing living donor liver transplantation â?? A Prospective Observational study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/10/037235
Enrollment
30
Registered
2021-10-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K740- Hepatic fibrosis

Interventions

Intervention1: Nil: Nil

Sponsors

Dr Swati Gupta
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All patients undergoing living donor liver transplantation

Exclusion criteria

Exclusion criteria: 1. Previous history of esophageal pathology like stricture, malignancy, diverticulum, laceration or history of previous esophageal surgery. 2. Esophageal varices > grade 2, gastric varices or active esophagitis. 4. History of recent upper gastro-intestinal bleed (within 1 month). 5. History of variceal banding within last month 5. Patient not willing to provide informed consent.

Design outcomes

Primary

MeasureTime frame
To evaluate portal vein, hepatic vein and IVC flow velocities using TEE immediately after the reperfusion during live donor liver transplant surgery.Timepoint: Baseline, 4 hours, 8 hours, 12 hours—

Secondary

MeasureTime frame
Any complication related to TEETimepoint: 48 Hours;Any major finding on TEE during liver transplantationTimepoint: 24 Hours;To find out the angle on TEE at which portal vein, hepatic vein and ivc are seenTimepoint: 24 Hours—

Countries

India

Contacts

Public ContactDr Gaurav Sindwani

Institute of Liver and Biliary Sciences

drsindwani25@gmail.com8728089898

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026